====== Tubacin 1.6μM R07 exp416 ======
==== Mechanism of Action ====
Inhibits HDAC6 selectively
* **Class / Subclass 1:** Gene Regulation / Epigenetic Inhibitor
==== Technical Notes ====
* **PubChem Name:** %%Tubacin%%
* **Synonyms:** N/A
* **CAS #:** 537049-40-4
* **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/6675804|6675804]]
* **IUPAC:** %%N-[4-[(2R,4R,6S)-4-[(4,5-diphenyl-1,3-oxazol-2-yl)sulfanylmethyl]-6-[4-(hydroxymethyl)phenyl]-1,3-dioxan-2-yl]phenyl]-N'-hydroxyoctanediamide%%
* **INCHI Name:** InChI=1S/C41H43N3O7S/c45-26-28-17-19-29(20-18-28)35-25-34(27-52-41-43-38(30-11-5-3-6-12-30)39(51-41)31-13-7-4-8-14-31)49-40(50-35)32-21-23-33(24-22-32)42-36(46)15-9-1-2-10-16-37(47)44-48/h3-8,11-14,17-24,34-35,40,45,48H,1-2,9-10,15-16,25-27H2,(H,42,46)(H,44,47)/t34-,35+,40+/m1/s1
* **INCHI Key:** BHUZLJOUHMBZQY-YXQOSMAKSA-N
* **Molecular Weight:** 721.9
* **Canonical SMILES:** C1C(OC(OC1C2=CC=C(C=C2)CO)C3=CC=C(C=C3)NC(=O)CCCCCCC(=O)NO)CSC4=NC(=C(O4)C5=CC=CC=C5)C6=CC=CC=C6
* **Isomeric SMILES:** C1[C@@H](O[C@@H](O[C@@H]1C2=CC=C(C=C2)CO)C3=CC=C(C=C3)NC(=O)CCCCCCC(=O)NO)CSC4=NC(=C(O4)C5=CC=CC=C5)C6=CC=CC=C6
* **Molecular Formula:** C41H43N3O7S
{{:chemogenomics:structures:chem-0249.svg?nolink}}
* **Supplier Name:** Med Chem Express
* **Catalog #:** HY-13428
* **Lot #:** 24226
* **HRMS (ESI-TOF) m/z:** (M+H)+ Calcd for C41H43N3O7S 722.28945; found 722.29004
* **Platform ID:** Tubacin
* **Min:** -14.5129; **Max:** 98.9010
{{:chemogenomics:dose_response:dr_410.png?nolink&500 |}}
\\
\\
\\
\\
|< 300px 100px 200px >|
^ IC ^ Concentration (µM) ^
| IC10 |N/A |
| IC20 |1.2421 |
| IC30 |1.4401 |
| IC40 |1.6505 |
| IC50 |1.8880 |
| IC60 |N/A |
| IC70 |N/A |
| IC80 |N/A |
| IC90 |N/A |
\\
==== Screen Summary ====
* **Round**: 07
* **Dose**: 1.6µM
* **Days of incubation**: 8
* **Doublings**: 2.2
* **Numbers of reads**: 22041208
==== Screen Results ====
^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^
|71/71|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/Tubacin_1.6uM_Round-7_exp416.txt|Scores]]||||||
{{:chemogenomics:cranks_plots:exp416.png?nolink}}
^Gene^CRANKS Score^FDR^
|[[:human_genes:A:ACSL3|ACSL3]]|-4.54|0.00|
|[[:human_genes:C:CYB561D2|CYB561D2]]|-4.34|0.00|
|[[:human_genes:R:RER1|RER1]]|-4.16|0.00|
|[[:human_genes:P:PSMB8|PSMB8]]|-4.01|0.00|
|[[:human_genes:G:GPR107|GPR107]]|-3.80|0.00|
|[[:human_genes:P:PSMB5|PSMB5]]|-3.58|0.00|
|[[:human_genes:N:NPRL3|NPRL3]]|-3.56|0.00|
|[[:human_genes:D:DDI2|DDI2]]|-3.55|0.00|
|[[:human_genes:K:KDSR|KDSR]]|-3.47|0.00|
|[[:human_genes:G:GCLM|GCLM]]|-3.38|0.00|
|[[:human_genes:N:NADK|NADK]]|-3.24|0.00|
|[[:human_genes:Y:YBX1|YBX1]]|-3.14|0.00|
|[[:human_genes:C:CNOT2|CNOT2]]|-3.04|<0.01|
|[[:human_genes:N:NPRL2|NPRL2]]|-2.97|<0.01|
|[[:human_genes:S:SPR|SPR]]|-2.95|<0.01|
|[[:human_genes:P:PCYT1A|PCYT1A]]|-2.90|<0.01|
|[[:human_genes:G:GMPPB|GMPPB]]|-2.88|0.02|
|[[:human_genes:F:FLVCR1|FLVCR1]]|-2.85|<0.01|
|[[:human_genes:S:SLC39A10|SLC39A10]]|-2.81|<0.01|
|[[:human_genes:N:NGLY1|NGLY1]]|-2.80|<0.01|
|[[:human_genes:P:PBRM1|PBRM1]]|-2.76|<0.01|
|[[:human_genes:P:PSENEN|PSENEN]]|-2.73|<0.01|
|[[:human_genes:P:PRKAA1|PRKAA1]]|-2.72|<0.01|
|[[:human_genes:T:TMEM189|TMEM189]]|-2.71|<0.01|
|[[:human_genes:M:MGA|MGA]]|-2.71|<0.01|
|[[:human_genes:A:AGPAT1|AGPAT1]]|-2.69|0.02|
|[[:human_genes:A:ARFRP1|ARFRP1]]|-2.68|<0.01|
|[[:human_genes:C:CEPT1|CEPT1]]|-2.68|<0.01|
|[[:human_genes:N:NCOR1|NCOR1]]|-2.67|<0.01|
|[[:human_genes:A:ALG9|ALG9]]|-2.60|<0.01|
|[[:human_genes:Q:QKI|QKI]]|2.92|<0.01|
|[[:human_genes:L:LZTR1|LZTR1]]|2.96|0.00|
|[[:human_genes:K:KCTD5|KCTD5]]|3.00|0.00|
|[[:human_genes:A:ALAD|ALAD]]|3.02|<0.01|
|[[:human_genes:F:FADS2|FADS2]]|3.09|<0.01|
|[[:human_genes:C:CELF2|CELF2]]|3.10|0.00|
|[[:human_genes:C:C19orf43|C19orf43]]|3.15|0.00|
|[[:human_genes:E:EIF3K|EIF3K]]|3.19|0.00|
|[[:human_genes:A:ALAS1|ALAS1]]|3.21|<0.01|
|[[:human_genes:P:PIH1D1|PIH1D1]]|3.32|0.00|
|[[:human_genes:T:TMEM208|TMEM208]]|3.36|0.00|
|[[:human_genes:O:ODC1|ODC1]]|3.36|0.00|
|[[:human_genes:S:SEC31A|SEC31A]]|3.41|0.00|
|[[:human_genes:C:CHD1|CHD1]]|3.43|0.00|
|[[:human_genes:M:MBTPS2|MBTPS2]]|3.55|0.00|
|[[:human_genes:M:MTF1|MTF1]]|3.63|0.00|
|[[:human_genes:S:SPI1|SPI1]]|3.80|0.00|
|[[:human_genes:E:EIF4A1|EIF4A1]]|3.86|0.00|
|[[:human_genes:G:GLRX5|GLRX5]]|3.89|0.00|
|[[:human_genes:R:RXRB|RXRB]]|3.98|0.00|
|[[:human_genes:D:DEGS1|DEGS1]]|4.00|0.00|
|[[:human_genes:H:HMBS|HMBS]]|4.05|0.00|
|[[:human_genes:A:ABCG1|ABCG1]]|4.11|0.00|
|[[:human_genes:I:IKZF1|IKZF1]]|4.12|0.00|
|[[:human_genes:U:UCHL5|UCHL5]]|4.32|0.00|
|[[:human_genes:T:TFPT|TFPT]]|4.55|0.00|
|[[:human_genes:C:C12orf49|C12orf49]]|5.68|0.00|
|[[:human_genes:N:NFRKB|NFRKB]]|5.71|0.00|
|[[:human_genes:R:RPRD1B|RPRD1B]]|5.99|0.00|
|[[:human_genes:F:FADS1|FADS1]]|6.36|0.00|
^Screen^Correlation^Plot^
|[[:results:exp84|UM0125461 0.74μM R02 exp84]]|0.149||
|[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|0.077||
|[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|0.074||
|[[:results:exp180|Dynasore 10μM R04 exp180]]|0.107||
|[[:results:exp450|Artemisinin 50μM R08 exp450]]|0.084||
|[[:results:exp436|Dynasore 7μM R08 exp436]]|0.083||
|[[:results:exp360|Genistein 15μM R07 exp360]]|0.078||
|[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|0.077||
|[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|0.077||
|[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|0.076||
|[[:results:exp517|Quercetin 20μM R08 exp517]]|0.069||
|[[:results:exp169|BH1 1μM R04 exp169]]|0.066||
|[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|0.062||
|[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|0.062||
|[[:results:exp461|BS-181 20μM R08 exp461]]|0.062||
|[[:results:exp468|CB-5083 0.4μM R08 exp468]]|0.062||
|[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|0.062||
|[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|0.058||
|[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|0.057||
|[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|0.055||
|[[:results:exp485|GSK626616 14μM R08 exp485]]|0.055||
|[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|0.054||
|[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|0.054||
|[[:results:exp497|Lead acetate 2000μM R08 exp497]]|0.053||
|[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|0.051||
|[[:results:exp515|PU-H71 1μM R08 exp515]]|0.051||
|[[:results:exp466|Cannabidiol 20μM R08 exp466]]|0.051||
|[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|0.051||
|[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|0.051||
|[[:results:exp365|I-BRD9 4μM R07 exp365]]|0.051||
{{:chemogenomics:comparison_plots:exp416_vs_exp84.png?nolink |}}
{{:chemogenomics:comparison_plots:exp416_vs_exp434.png?nolink |}}
{{:chemogenomics:comparison_plots:exp416_vs_exp89.png?nolink |}}
{{:chemogenomics:comparison_plots:exp180_vs_exp416.png?nolink |}}
{{:chemogenomics:comparison_plots:exp416_vs_exp450.png?nolink |}}
{{:chemogenomics:comparison_plots:exp416_vs_exp436.png?nolink |}}
{{:chemogenomics:comparison_plots:exp360_vs_exp416.png?nolink |}}
{{:chemogenomics:comparison_plots:exp356_vs_exp416.png?nolink |}}
{{:chemogenomics:comparison_plots:exp329_vs_exp416.png?nolink |}}
{{:chemogenomics:comparison_plots:exp416_vs_exp529.png?nolink |}}
{{:chemogenomics:comparison_plots:exp416_vs_exp517.png?nolink |}}
{{:chemogenomics:comparison_plots:exp169_vs_exp416.png?nolink |}}
{{:chemogenomics:comparison_plots:exp35_vs_exp416.png?nolink |}}
{{:chemogenomics:comparison_plots:exp164_vs_exp416.png?nolink |}}
{{:chemogenomics:comparison_plots:exp416_vs_exp461.png?nolink |}}
{{:chemogenomics:comparison_plots:exp416_vs_exp468.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp416.png?nolink |}}
{{:chemogenomics:comparison_plots:exp416_vs_exp6.png?nolink |}}
{{:chemogenomics:comparison_plots:exp407_vs_exp416.png?nolink |}}
{{:chemogenomics:comparison_plots:exp416_vs_exp454.png?nolink |}}
{{:chemogenomics:comparison_plots:exp416_vs_exp485.png?nolink |}}
{{:chemogenomics:comparison_plots:exp36_vs_exp416.png?nolink |}}
{{:chemogenomics:comparison_plots:exp25_vs_exp416.png?nolink |}}
{{:chemogenomics:comparison_plots:exp416_vs_exp497.png?nolink |}}
{{:chemogenomics:comparison_plots:exp416_vs_exp445.png?nolink |}}
{{:chemogenomics:comparison_plots:exp416_vs_exp515.png?nolink |}}
{{:chemogenomics:comparison_plots:exp416_vs_exp466.png?nolink |}}
{{:chemogenomics:comparison_plots:exp416_vs_exp489.png?nolink |}}
{{:chemogenomics:comparison_plots:exp416_vs_exp68.png?nolink |}}
{{:chemogenomics:comparison_plots:exp365_vs_exp416.png?nolink |}}
^GO Term^Fold Change^Genes^
|GATOR1 complex|592.11|NPRL3,NPRL2|
^GO Term^Fold Change^Genes^
|acyl-CoA desaturase activity|368.42|FADS1,FADS2|
|protoporphyrinogen IX metabolic process|221.05|HMBS,ALAS1,ALAD,FECH|
|protoporphyrinogen IX biosynthetic process|207.24|HMBS,ALAS1,ALAD|
|Ino80 complex|127.53|NFRKB,TFPT,UCHL5|
|positive regulation of telomere maintenance in response to DNA damage|127.53|NFRKB,TFPT,UCHL5|
|regulation of DNA strand elongation|110.53|NFRKB,TFPT,UCHL5|
|regulation of telomere maintenance in response to DNA damage|97.52|NFRKB,TFPT,UCHL5|
|heme biosynthetic process|88.42|HMBS,ALAS1,ALAD,FECH|
|porphyrin-containing compound biosynthetic process|78.95|HMBS,ALAS1,ALAD,FECH|
|tetrapyrrole biosynthetic process|78.95|HMBS,ALAS1,ALAD,FECH|
|INO80-type complex|69.08|NFRKB,TFPT,UCHL5|
|heme metabolic process|56.68|HMBS,ALAS1,ALAD,FECH|
|pigment biosynthetic process|53.92|HMBS,ALAS1,ALAD,FECH|
|porphyrin-containing compound metabolic process|48.06|HMBS,ALAS1,ALAD,FECH|
|unsaturated fatty acid biosynthetic process|44.81|FADS1,DEGS1,FADS2|
|tetrapyrrole metabolic process|40.94|HMBS,ALAS1,ALAD,FECH|
|pigment metabolic process|34.54|HMBS,ALAS1,ALAD,FECH|
|erythrocyte differentiation|23.52|IKZF1,SPI1,ALAS1,FECH|
|erythrocyte homeostasis|21.46|IKZF1,SPI1,ALAS1,FECH|